JMPWA
TXMD icon

JP Morgan Private Wealth Advisors’s TherapeuticsMD TXMD Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-380
Closed -$69K – 1509
2019
Q3 		$69K Buy
+380
New +$53.6K ﹤0.01% 1402
2018
Q4 		– Sell
-1,120
Closed -$367K – 1592
2018
Q3 		$367K Buy
+1,120
New +$343K ﹤0.01% 1204

Other funds holding TXMD

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Private Wealth Advisors's TXMD Position: Q4 2019 in Review

JP Morgan Private Wealth Advisors sold out of TherapeuticsMD (TXMD) in Q4 2019, closing a stake of 380 shares — an estimated $69K sold.

JP Morgan Private Wealth Advisors first reported a position in TXMD in Q3 2018 and held it in 2 quarters. The position peaked at $367K in Q3 2018. 168 funds tracked by Wall St. Rank hold TXMD as of Q4 2019.

  • JP Morgan Private Wealth Advisors reported no remaining TherapeuticsMD position as of Q4 2019 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 380 TherapeuticsMD shares in Q4 2019, an estimated $69K.
  • JP Morgan Private Wealth Advisors first reported a position in TherapeuticsMD in Q3 2018 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's TherapeuticsMD position peaked at $367K in Q3 2018.
  • 168 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.